|19.60||-0.34 / -1.71%|
As of 3:59pm ET
|19.60||0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 24.00, with a high estimate of 25.00 and a low estimate of 23.00. The median estimate represents a +22.45% increase from the last price of 19.60.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.